Microbial GenomicsGenomicsPeer-reviewed journal article
Chlamydia trachomatis outbreak: when the virulence-associated genome backbone imports a prevalence-associated major antigen signature
Vítor BorgesiD, Dora CordeiroiD, Ana Isabel Salas, Zohra LodhiaiD, Cristina Belo CorreiaiD, Joana IsidroiD, Cândida FernandesiD, Ana Maria RodriguesiD, Jacinta AzevedoiD, João Alves, João RôxoiD, Miguel RochaiD, Rita Côrte‐Real, Luı́s VieiraiD, Maria José BorregoiD, João Paulo GomesiD
Abstract
Chlamydia trachomatis is the most prevalent sexually transmitted bacteria worldwide and the causative agent of blinding trachoma. Strains are classified based on ompA genotypes, which are strongly linked with differential tissue tropism and disease outcomes. A lymphogranuloma venereum (LGV) epidemics, characterized by ulcerative proctitis, has emerged in the last two decades (mainly L2b genotype), raising high concern especially due to its circulation among men who have sex with men (MSM). Here, we report an ongoing outbreak (mostly affecting HIV-positive MSM engaging in high-risk practices) caused by an L2b strain with a rather unique genome makeup that precluded the laboratory notification of this outbreak as LGV due to its non-LGV ompA signature. Homologous recombination mediated the transfer of a ~4.5Kbp fragment enrolling CT681/ompA and neighboring genes (CT677/rrf, CT678/pyrH, CT679/tsf, CT680/rpsB) from a serovar D/Da strain likely possessing the typical T1 clade genome backbone associated with most prevalent genotypes (E and F). The hybrid L2b/D-Da strain presents the adhesin and immunodominant antigen MOMP (coded by ompA) with an epitope repertoire typical of non-invasive genital strains, while keeping the genome-dispersed virulence fingerprint of a classical LGV (L2b) strain. As previously reported for inter-clade ompA exchange among non-LGV clades, this unprecedented C. trachomatis genomic mosaic involving a contemporary epidemiologically and clinically relevant LGV strain may have implications on its transmission, tissue tropism and pathogenic capabilities. The emergence of such variants with epidemic and pathogenic potential highlights the need of more oriented surveillance strategies focused on capturing the C. trachomatis evolution in action.
- organism: bacteria (other)
- assay: whole-genome sequencing
- research focus: genome assembly
- research focus: variant calling
- research focus: differential expression
- approach: experimental assay
- Citations
- 38
- FWCI
- 2.94
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chlamydia trachomatis genomes from rectal samples: description of new clade comprising ompA-genotype L4 from Argentina
Karina Andrea Büttner, Fanny Wegner, … On behalf of the ESCMID Study Group for Mycoplasma and Chlamydia infections (ESGMAC)*·Microbial GenomicsPeer-reviewed·Feb 13, 2025
- Patterns of within-host spread of Chlamydia trachomatis between vagina, endocervix and rectum revealed by comparative genomic analysis
S. J. Joseph, S. Bommona, … T. D. Read·bioRxiv·Jan 25, 2023
- Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity
Anna R. Last, Harry C. Pickering, … Martin J. Holland·Genome MedicinePeer-reviewed·Feb 26, 2018
- Whole-Genome Enrichment and Sequencing of Chlamydia trachomatis Directly from Patient Clinical Vaginal and Rectal Swabs
Katherine E. Bowden, Sandeep J. Joseph, … Deborah Dean·mSpherePeer-reviewed·Mar 5, 2021
- Genomic insights into local scale evolution of ocular Chlamydia trachomatis strains within and between individuals in Gambian trachoma-endemic villages
Ehsan Ghasemian, Nkoyo Faal, … Martin J. Holland·Microbial GenomicsPeer-reviewed·Mar 6, 2024
- Genomics of Ocular Chlamydia trachomatis after 5 years of SAFE interventions for trachoma in Amhara, Ethiopia
Harry C. Pickering, Ambahun Chernet, … Scott D. Nash·The Journal of Infectious DiseasesPeer-reviewed·Sep 30, 2020